Home › Bayer sues Mylan over plans for generic cancer treatment drug
 

Keywords :   


Bayer sues Mylan over plans for generic cancer treatment drug

2015-02-09 20:10:04| Chemicals - Topix.net

Bayer Healthcare LLC is suing Mylan Inc. over the Southpointe drugmaker's application to make a generic version of cancer treatment Nexavar. Mylan confirmed the lawsuit in the U.S. District Court in Delaware by Bayer Healthcare LLC, Bayer Healthcare Pharmaceuticals Inc. and Onyx Pharmaceuticals over Mylan's abbreviated new drug application to the Food and Drug Administration for a 200 mg Sorafenib tablet.

Tags: plans treatment drug cancer

Category:Chemicals

Latest from this category

All news
01.11BASF TotalEnergies Petrochemicals Receives United Way Champions of Hope Award
31.10Nippon Paint Holdings to Acquire AOC from Lone Star Funds
31.10RPM Acquires TMP Convert
31.10AkzoNobels Largest European Solar Energy Plant Goes Live in Poland
30.10BASF Groups EBITDA Before Special Items Up from Q3 2023
30.10Axalta Reports Record Net Sales in 3Q 2024
30.10Zack Hays Joins Orion S.A. as Marketing Manager
30.10UK Linseed Paint Maker Launches US Venture
Chemicals »
01.11CERM launches new MIS products, Mark Andy innovates and more
01.11Getting more out of fall and winter grazing
01.11U.S. Boston butt burger launches in Colombia
01.11All Americans have a role in keeping African swine fever out
01.11BASF TotalEnergies Petrochemicals Receives United Way Champions of Hope Award
01.11US jobs growth slows as presidential election looms
01.11Heritage Environmental Services Secures Commercial Permit Status for Orange, TX Incinerator
01.11Value for Money tsar linked to string of overspends
More »